Eupraxia Pharmaceuticals News - August 13, 2026
🟢 Eupraxia Pharmaceuticals is trading 6% up today after Q2 earnings beat
Eupraxia Pharmaceuticals is trading 5.71% up now at $6.85 after its August 11, 2026 second-quarter earnings beat. - The results were supported by a $133.6...
🟢 Eupraxia Pharmaceuticals is trading 13% up in pre-market after Q2 report highlighted $133.7 million liquidity
Eupraxia Pharmaceuticals is trading sharply higher at $7.30, up +12.65%, after its August 11 Q2 report highlighted $133.7 million in liquidity and cash runway...
🟢 Eupraxia Pharmaceuticals is trading 8% up today in pre-market after Q2 EPS beat
Eupraxia Pharmaceuticals is trading $7.00 (+8.02%) in pre-market after reporting Q2 EPS of $(0.23), beating the $(0.25) estimate. - Management reported $133.7...